A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
NCT02835469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412
Last updated 2019-03-28
Summary
The purpose of this study is to investigate the ongoing pregnancy rates at 10-11 weeks after embryo transfer in patients treated with Menopur® Multidose
Conditions
Interventions
- DRUG
-
Menotrophin
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Clinical Development Support · Ferring Pharmaceuticals
Eligibility
- Min Age
- 19 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2019-02-01
- Completion
- 2019-02-01
Countries
- South Korea
Study Locations
More Related Trials
-
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
NCT00257556 ·Status: COMPLETED ·Phase: PHASE4
-
MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer
NCT00884221 ·Status: COMPLETED ·Phase: PHASE3
-
Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART
NCT01107470 ·Status: UNKNOWN
-
Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility
NCT01250821 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733 ·Status: COMPLETED
-
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients
NCT02330757 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
NCT02935335 ·Status: COMPLETED
-
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT07216742 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
NCT00971152 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
NCT00296465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
NCT02865681 ·Status: COMPLETED ·Phase: NA
-
Stop Menstruation and Pregnancy Rates in Antagonist Protocol
NCT01357473 ·Status: COMPLETED
-
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
NCT00669786 ·Status: COMPLETED ·Phase: PHASE3
-
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
NCT01888744 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP
NCT01330771 ·Status: COMPLETED
-
Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)
NCT00702546 ·Status: COMPLETED
-
A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women
NCT04902131 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
NCT03373149 ·Status: UNKNOWN ·Phase: PHASE2
-
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
NCT04356664 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)
NCT01109654 ·Status: COMPLETED
-
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
NCT05969795 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients
NCT01312766 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
NCT05569577 ·Status: RECRUITING ·Phase: NA
-
Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients
NCT01298960 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer
NCT06379659 ·Status: COMPLETED ·Phase: PHASE1/PHASE2